which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Familial essential thrombocythemia features the acquisition of somatic mutations and an evolution similar to the sporadic form of the disease. Here we report two patients—father and daughter—with essential thrombocythemia who displayed a heterogeneous pattern of somatic mutations. The JAK2 V617F mutation was found in the daughter, while the father harbored the MPL W515L mutation. This case report may constitute further proof that in familial essential thrombocythemia there are other, still undefined, constitutional, inherited genetic factors predisposing to the acquisition of various somatic mutations (e.g., JAK2 V617F...
Background: Familial thrombocythemia is a rare chronic myeloproliferative disorder caused by molecul...
The novel H608N mutation is mapped in exon 14, as the classic V617F mutation. Histidine 608 belongs ...
Essential thrombocythemia (ET) is rare in children, and little or no information is available about ...
Familial essential thrombocythemia features the acquisition of somatic mutations and an evolution si...
Rarely essential thrombocythemia (ET) is diagnosed in more than one person within a family. Familial...
Abstract Essential thrombocythemia (ET) is extremely rare in the pediatric population. In most pati...
Familial chronic myeloproliferative disorders are defined when in the same pedigree at least two rel...
• JAK2R564Q is the first germline JAK2 mutation found to contribute to a familial MPN that involves ...
The JAK2(V617F) mutation occurs in 50% of patients with essential thrombocythemia (ET). We investiga...
of the Literature. J Hematol Thromb Dis 2: 180. doi: 10.4172/2329-8790.1000180 Copyright: © 2014 Mi...
Familial thrombocytosis can be divided into two broad categories. The first includes inherited syndr...
International audienceIn this study, we report on a family with a germline JAK2 G571S mutation with ...
Among 994 patients with essential thrombocythemia (ET) who were genotyped for the MPLW515UK mutation...
Satoh A, et al. Familial essential thrombocythemia associ-ated with a dominant-positive activating m...
Essential thrombocythemia (ET) is rare in children, and little or no information is available about ...
Background: Familial thrombocythemia is a rare chronic myeloproliferative disorder caused by molecul...
The novel H608N mutation is mapped in exon 14, as the classic V617F mutation. Histidine 608 belongs ...
Essential thrombocythemia (ET) is rare in children, and little or no information is available about ...
Familial essential thrombocythemia features the acquisition of somatic mutations and an evolution si...
Rarely essential thrombocythemia (ET) is diagnosed in more than one person within a family. Familial...
Abstract Essential thrombocythemia (ET) is extremely rare in the pediatric population. In most pati...
Familial chronic myeloproliferative disorders are defined when in the same pedigree at least two rel...
• JAK2R564Q is the first germline JAK2 mutation found to contribute to a familial MPN that involves ...
The JAK2(V617F) mutation occurs in 50% of patients with essential thrombocythemia (ET). We investiga...
of the Literature. J Hematol Thromb Dis 2: 180. doi: 10.4172/2329-8790.1000180 Copyright: © 2014 Mi...
Familial thrombocytosis can be divided into two broad categories. The first includes inherited syndr...
International audienceIn this study, we report on a family with a germline JAK2 G571S mutation with ...
Among 994 patients with essential thrombocythemia (ET) who were genotyped for the MPLW515UK mutation...
Satoh A, et al. Familial essential thrombocythemia associ-ated with a dominant-positive activating m...
Essential thrombocythemia (ET) is rare in children, and little or no information is available about ...
Background: Familial thrombocythemia is a rare chronic myeloproliferative disorder caused by molecul...
The novel H608N mutation is mapped in exon 14, as the classic V617F mutation. Histidine 608 belongs ...
Essential thrombocythemia (ET) is rare in children, and little or no information is available about ...